CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 25 of 910 entries

View as:

Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)

Phase: N/A Priority: Normal

NCT ID: NCT01012596 Org: User:

Start: 10/31/09 End: 05/31/13 Due: 05/31/14

Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease

Phase: N/A Priority: Normal

NCT ID: NCT01350388 Org: User:

Start: 05/31/11 End: 12/31/13 Due: 12/31/14

Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation

Phase: N/A Priority: Normal

NCT ID: NCT04130061 Org: User:

Start: 10/11/19 End: 06/01/21 Due: 06/01/22

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Phase: N/A Priority: Normal

NCT ID: NCT01968590 Org: User:

Start: 08/16/17 End: 01/01/22 Due: 01/01/23

Intramedullary Nailing of Tibia Fractures

Phase: N/A Priority: Normal

NCT ID: NCT01797640 Org: User:

Start: 10/31/12 End: 04/30/15 Due: 04/30/16

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

Phase: N/A Priority: Normal

NCT ID: NCT00694096 Org: User:

Start: 09/30/07 End: 09/30/14 Due: 09/30/15

Gonadal Radiation Exposure and Risk Secondary to Fluoroscopic Imaging During Trauma Surgery

Phase: N/A Priority: Normal

NCT ID: NCT02267330 Org: User:

Start: 02/29/12 End: 05/31/15 Due: 05/31/16

Hyperhidrosis in Patients With Amputations-Botox

Phase: N/A Priority: Normal

NCT ID: NCT03236012 Org: User:

Start: 01/08/19 End: 02/14/22 Due: 02/14/23

Eating Mindfully to Prevent Weight Regain

Phase: N/A Priority: Normal

NCT ID: NCT04847843 Org: User:

Start: 06/16/21 End: 05/22/24 Due: 05/22/25

Surgical Treatment of Adult Trigger Finger

Phase: N/A Priority: Normal

NCT ID: NCT02196233 Org: User:

Start: 11/30/12 End: 07/31/19 Due: 07/31/20

Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain

Phase: N/A Priority: Normal

NCT ID: NCT02935621 Org: User:

Start: 04/01/17 End: 12/15/22 Due: 12/15/23

Shoulder RFA Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT06039345 Org: User:

Start: 02/07/24 End: 02/28/25 Due: 02/28/26

Decreasing Nightmares in Adults with Narcolepsy

Phase: N/A Priority: Normal

NCT ID: NCT06383806 Org: User:

Start: 03/31/25 End: 09/30/26 Due: 09/30/27

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Phase: N/A Priority: Normal

NCT ID: NCT00346853 Org: User:

Start: 11/30/05 End: 09/30/06 Due: 09/30/07

In Vivo Assessment of Silver Biomaterial Nano-Toxicity

Phase: N/A Priority: Normal

NCT ID: NCT01243320 Org: User:

Start: 12/31/10 End: 07/31/11 Due: 07/31/12

Progressive Strength Training in Spinal Muscular Atrophy

Phase: N/A Priority: Normal

NCT ID: NCT01233817 Org: User:

Start: 06/30/10 End: 06/30/13 Due: 06/30/14

Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds

Phase: N/A Priority: Normal

NCT ID: NCT04438174 Org: User:

Start: 08/31/22 End: 03/31/23 Due: 03/31/24

Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients

Phase: N/A Priority: Normal

NCT ID: NCT04497389 Org: User:

Start: 10/28/20 End: 02/15/23 Due: 02/15/24

Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome

Phase: N/A Priority: Normal

NCT ID: NCT01405729 Org: User:

Start: 05/31/10 End: 12/31/13 Due: 12/31/14

Urine Concentration of S100B in Extremely Premature Infants

Phase: N/A Priority: Normal

NCT ID: NCT00747591 Org: User:

Start: 11/30/02 End: 04/30/05 Due: 04/30/06

Angiotensinogen Variants and Adverse Pregnancy Outcomes

Phase: N/A Priority: Normal

NCT ID: NCT00005400 Org: User:

Start: 08/31/95 End: 07/31/03 Due: 07/31/04

Hydrus Learning Curve Study

Phase: N/A Priority: Normal

NCT ID: NCT06964139 Org: User:

Start: 12/12/24 End: 07/31/25 Due: 07/31/26

Shoulder Pacemaker for Scapular Dyskinesia

Phase: N/A Priority: Normal

NCT ID: NCT05116722 Org: User:

Start: 09/27/21 End: 09/30/27 Due: 09/30/28

Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma (R+Pirto in Newly Diagnosed MZL)

Phase: N/A Priority: Normal

NCT ID: NCT06390956 Org: User:

Start: 01/28/25 End: 12/31/32 Due: 12/31/33

Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00204698 Org: User:

Start: 08/31/03 End: 05/31/06 Due: 05/31/07

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)	NCT01012596	University of Utah	user2@example.com	None	2009-10-31	2013-05-31	2014-05-31	-	-	2025-07-14
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease	NCT01350388	University of Utah	user2@example.com	None	2011-05-31	2013-12-31	2014-12-31	-	-	2025-07-14
Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation	NCT04130061	University of Utah	user2@example.com	None	2019-10-11	2021-06-01	2022-06-01	-	-	2025-07-14
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)	NCT01968590	University of Utah	user2@example.com	None	2017-08-16	2022-01-01	2023-01-01	-	-	2025-07-14
Intramedullary Nailing of Tibia Fractures	NCT01797640	University of Utah	user2@example.com	None	2012-10-31	2015-04-30	2016-04-30	-	-	2025-07-14
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response	NCT00694096	University of Utah	user2@example.com	None	2007-09-30	2014-09-30	2015-09-30	-	-	2025-07-14
Gonadal Radiation Exposure and Risk Secondary to Fluoroscopic Imaging During Trauma Surgery	NCT02267330	University of Utah	user2@example.com	None	2012-02-29	2015-05-31	2016-05-31	-	-	2025-07-14
Hyperhidrosis in Patients With Amputations-Botox	NCT03236012	University of Utah	user2@example.com	None	2019-01-08	2022-02-14	2023-02-14	-	-	2025-07-14
Eating Mindfully to Prevent Weight Regain	NCT04847843	University of Utah	user2@example.com	None	2021-06-16	2024-05-22	2025-05-22	-	-	2025-07-14
Surgical Treatment of Adult Trigger Finger	NCT02196233	University of Utah	user2@example.com	None	2012-11-30	2019-07-31	2020-07-31	-	-	2025-07-14
Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain	NCT02935621	University of Utah	user2@example.com	None	2017-04-01	2022-12-15	2023-12-15	-	-	2025-07-14
Shoulder RFA Pilot Study	NCT06039345	University of Utah	user2@example.com	None	2024-02-07	2025-02-28	2026-02-28	-	-	2025-07-14
Decreasing Nightmares in Adults with Narcolepsy	NCT06383806	University of Utah	user2@example.com	None	2025-03-31	2026-09-30	2027-09-30	-	-	2025-07-14
Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy	NCT00346853	University of Utah	user2@example.com	None	2005-11-30	2006-09-30	2007-09-30	-	-	2025-07-14
In Vivo Assessment of Silver Biomaterial Nano-Toxicity	NCT01243320	University of Utah	user2@example.com	None	2010-12-31	2011-07-31	2012-07-31	-	-	2025-07-14
Progressive Strength Training in Spinal Muscular Atrophy	NCT01233817	University of Utah	user2@example.com	None	2010-06-30	2013-06-30	2014-06-30	-	-	2025-07-14
Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds	NCT04438174	University of Utah	user2@example.com	None	2022-08-31	2023-03-31	2024-03-31	-	-	2025-07-14
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients	NCT04497389	University of Utah	user2@example.com	None	2020-10-28	2023-02-15	2024-02-15	-	-	2025-07-14
Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome	NCT01405729	University of Utah	user2@example.com	None	2010-05-31	2013-12-31	2014-12-31	-	-	2025-07-14
Urine Concentration of S100B in Extremely Premature Infants	NCT00747591	University of Utah	user2@example.com	None	2002-11-30	2005-04-30	2006-04-30	-	-	2025-07-14
Angiotensinogen Variants and Adverse Pregnancy Outcomes	NCT00005400	University of Utah	user2@example.com	None	1995-08-31	2003-07-31	2004-07-31	-	-	2025-07-14
Hydrus Learning Curve Study	NCT06964139	University of Utah	user2@example.com	None	2024-12-12	2025-07-31	2026-07-31	-	-	2025-07-14
Shoulder Pacemaker for Scapular Dyskinesia	NCT05116722	University of Utah	user2@example.com	None	2021-09-27	2027-09-30	2028-09-30	-	-	2025-07-14
Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma (R+Pirto in Newly Diagnosed MZL)	NCT06390956	University of Utah	user2@example.com	None	2025-01-28	2032-12-31	2033-12-31	-	-	2025-07-14
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment	NCT00204698	University of Utah	user2@example.com	None	2003-08-31	2006-05-31	2007-05-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance